ROMJ Rubicon Organics

Rubicon Organics Announces Health Canada Cultivation License For Cascadia (Hope, BC) Facility

Rubicon Organics Announces Health Canada Cultivation License For Cascadia (Hope, BC) Facility

  • 40% increase in cultivation capacity expected to drive revenue and EBITDA growth in Rubicon’s premium cannabis products 

  • The Company also announces the naming of cultivation facilities to Pacifica (previously “Delta Facility”) and Cascadia (previously “Hope Facility”).



VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling organic certified, premium and super-premium cannabis products, today announced the Cascadia facility, located in Hope, British Columbia, has received its license to cultivate, process, and store cannabis from Health Canada.

The license will enable Rubicon to begin cultivating cannabis at the 47,500 square foot, purpose-built indoor facility, already equipped with advanced cultivation technologies. This new facility will provide an additional 4,500kg of production capacity, representing an incremental 40% on existing capacity, bringing our total annual capacity to 15,500kg of premium cannabis.

Operations at the Cascadia facility are now underway. The Company expects first revenue in the first half of 2026.

“The receipt of this license is a significant step in the transformation of Rubicon Organics. This additional 40% capacity will allow Rubicon to meet currently unmet demand for our award-winning premium products in Canada and in additional markets.” said Margaret Brodie, CEO. “Our newly-licensed Cascadia facility will also provide us with an indoor cultivation environment in which I expect certain cannabis strains will perform well, as well as additional capacity to begin addressing the international market opportunities for premium branded Rubicon product.”

Naming of Facilities - Pacifica and Cascadia

Rubicon Organics is also pleased to announced the naming of the existing Delta, B.C. and Hope, B.C. facilities, to Pacifica and Cascadia, respectively. This naming reflects the company’s legacy West Coast culture and expanded domestic and international focus.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics is the Canadian leader in certified organic and premium cannabis. With a vertically integrated model and strong national distribution, the company is scaling a house of trusted, high-performing brands including Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™.

The Company’s production base is anchored by its Delta, BC Facility, and is now complemented by the acquisition of its Hope, BC facility which will expand production capacity by over 40% and support future growth in both domestic and export markets. With proprietary genetics, award-winning products, and certifications enabling international distribution, Rubicon is positioned at the forefront of the premium cannabis segment.

As the Canadian market continues to rationalize and global demand for high-quality cannabis increases, Rubicon’s disciplined execution, brand equity, and consumer loyalty set it apart. The Company’s focus on premium quality, innovation, and operational execution has driven consistent revenue growth and positive Adjusted EBITDA.

Rubicon Organics represents a rare combination of category leadership, operational strength, and long-term growth potential.

CONTACT INFORMATION

Margaret Brodie

CEO

Phone: +1 (437) 929-1964

Email:

The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs; the expected benefits of the Hope Facility acquisition on the Company’s production capacity and growth strategy; the anticipated timing for commencement of operations, first harvests, and revenue generation from the Hope Facility; and the Company’s ability to meet growing consumer demand are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based on certain assumptions that management considers reasonable under the circumstances, including expectations regarding the activation, cultivation, and production capacity of the Cascadia facility, anticipated timelines for planting and revenue generation, growing demand of the Company’s leading brand portfolio in domestic and international markets, the acceleration of the Company’s growth beyond its existing footprint, projected start-up costs, and the impact of the Cascadia facility on the Company’s business. These statements are based on current expectations, estimates, and projections about the Company’s business and the industry in which it operates. Risks and uncertainties associated with the forward-looking information in this press release include, among others, risks related to regulatory approvals, changes in market conditions, competition, supply chain disruptions, the Company’s ability to maintain certification standards, and the successful implementation of its business strategy. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.



EN
20/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Rubicon Organics

 PRESS RELEASE

Rubicon Organics Announces Health Canada Cultivation License For Casca...

Rubicon Organics Announces Health Canada Cultivation License For Cascadia (Hope, BC) Facility 40% increase in cultivation capacity expected to drive revenue and EBITDA growth in Rubicon’s premium cannabis products The Company also announces the naming of cultivation facilities to Pacifica (previously “Delta Facility”) and Cascadia (previously “Hope Facility”). VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), Canada’s leading premium licensed producer focused on cultivating...

Ben Pirie
  • Ben Pirie

ROMJ: Premium Cannabis Leader Poised for Accelerated Growth

What you need to know: • Rubicon has grown revenue at a 44% CAGR since 2020, while outpacing industry growth and limiting dilution. We expect growth to accelerate in 2026 as ROMJ brings online its new Cascadia facility. • Rubicon has posted positive adjusted EBITDA since 2022, with margins expected to reach 10% in 2025 and 14% in 2026. • While cannabis equities remain at depressed valuation levels, Rubicon represents a high-quality name with a track record of growth and the backing of an elite m...

 PRESS RELEASE

Rubicon Organics to Present at Small Cap Discoveries in Vancouver and ...

Rubicon Organics to Present at Small Cap Discoveries in Vancouver and Planet MicroCap Showcase in Toronto VANCOUVER, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling organic certified, premium and super-premium cannabis products, is pleased to announce its participation in two upcoming investor-focused events: Small Cap Discoveries, taking place September 29–30 in Vancouver, and the Planet MicroCap Showcase: TORONTO, sch...

 PRESS RELEASE

Rubicon Organics Reports Q2 2025 Financial and Operating Results

Rubicon Organics Reports Q2 2025 Financial and Operating Results Delivered Q2 2025 net revenue of $15.0 million, representing a 24% increase compared to the same quarter in prior year, and 2025 YTD net revenue of $27.4 million, representing a 30% increase compared to the same six months in prior yearGenerated Adjusted EBITDA1 of $1.4 million in Q2 2025 and $2.1 million for 2025 YTDCompleted purchase of the Hope Facility, increasing total future capacity by 40%Completed a private placement for aggregate gross proceeds of $4.5 million1964 Launched Premium All-in-One Resin Vapes, Expands Into ...

 PRESS RELEASE

Rubicon Organics to Report Q2 2025 Results

Rubicon Organics to Report Q2 2025 Results VANCOUVER, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, will release its financial results for the three and six months ended June 30, 2025 (“Q2 2025”) before market open on Monday, August 18, 2025. The Company will host a conference call to discuss Q2 2025 results on Monday, August 18, 2025. Conference call details are as follows: Time:7:00 AM PT /...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch